NEW YORK--(BUSINESS WIRE)--OneMedPlace today announced the program for its 5th annual “OneMedForum San Francisco 2012” that will feature panels on investment opportunities in healthcare and life sciences along with company presentations. The event will be held January 9th -12th, 2012, at the Sir Francis Drake Hotel in San Francisco.
“Our objective is to give investors insight into areas of opportunity and the chance to meet the management of some of the most promising growth companies in the world,” said OneMedPlace founder Brett Johnson. “The financial sector has undergone extraordinary stress, yet opportunities abound for long-term investors in promising companies. The healthcare sector is dramatically evolving, and the future belongs to innovative companies with new approaches which is the focus of this conference.”
In addition to panels of leading investors and analysts discussing areas of greatest opportunity, the event will feature presentations by CEOs of more than 100 medical technology, biotechnology, and health technology companies on both public and private company tracks. The best technologies from leading universities ready for commercialization will also be featured along with workshops on finance and operations.
Panels include: “Investment Trends in Medical Devices,” which will provide an overview of major developments in medical device investing including Cardiology, Neurology, Orthopedics, Nanotechnology, Ophthalmology and Diabetes. A panel on “Investment Trends in Biotechnology” will share major developments in biotechnology investing; including regenerative medicine, neurological disorders, vaccines, and infectious diseases. In the panel “What the Healthcare System Needs,” the largest consumers of healthcare in the U.S. will describe areas of unmet need. The panel “Mobile Health and Medical Devices,” will discuss how the Internet has ushered in a new era in medical device development. OneMedForum’s “Diagnostics and Personalized Medicine” session will evaluate the risks and opportunities as personalized medicine becomes integrated into the healthcare system. A session entitled “Novel Health Information Technologies” will address how the transformation of healthcare delivery is having a critical strategic impact on large healthcare organizations. The event will consider international issues with a panel on India and the China Forum II, an afternoon of panels on January 9th focused on how Western companies can enter this rapidly growing market. Additionally a panel on ”The Globalization of Healthcare” will provide insights from CEOs of some of the world’s leading global medical technology companies.
Companies confirmed to present as of November 21st include: Del Mar Pharmaceuticals, EpiCept Corp. [EPCT], ADVENTRX Pharmaceuticals [ANX], ImmunoGenetix Therapeutics, Hepregen, WaferGenBiosystems [WGBS], Spherix Inc. [SPEX], ADS Biotechnology Ltd., SEA Medical Systems Inc., GlySure, Soft Tissue Regeneration Inc., VisionCareOphthalmic Technologies Inc., Bmeye, NanoViricides [NNVC], Cardium Therapeutics [CXM], CVAC Systems, ThermoGenesis [KOOL], Wound Management Technologies Inc. [WNDM], Biovista, Excelimmune, Bacterin International [BIHI], PLC Medical Systems [PLCSF], International Holdings Inc., Mirna Therapeutics Inc., DATATRAK International [DATA.PK], TONIX Pharmaceuticals Inc. [TNXP], AP Pharma, Novadaq Technologies Inc. [NDQ.TO], CytoSorbents [CTSO], Neovasc [NVC.V], Cytograft Tissue Engineering, Castlewood Surgical, Cyclacel Pharmaceuticals [CYCC], SpectraScience [SCIE], LoneStar Heart, Interface Biologics, NeoGenomics [NGNM], Vigilant Biosciences, Vimecon GMBH, AvitaMedical [ASX:AVH], Genta Inc. [GNTA], CorInnova Inc., Fibrocell Science [FCSC], 2B Blackbio, Advaxis Inc. [ADXS], Cervilenz Inc., Microvisk Ltd., Intellect Neurosciences [ILNS], RadLogics, MiraCor Medical System GMBH, Histogenics Corp., Symetis, InfoBionic, HyGreen Inc., Strohl Medical, Biocept Inc., ISCHEM Corp., Active Implants Corp., QLIDA, Colby Pharmaceuticals, Genomic Expression, CeQur. Profiles on the companies can be found on the conference web site: www.onemedforum.com
Public company presentations will be video-webcasted live on the Internet by OneMedTV starting 8:00 A.M. Tuesday January 11th.
Founded in 2008, OneMedForum is a biannual event held in San Francisco and in New York. OneMedForum creates a platform for emerging companies to connect with strategic partners and investors. Sponsors for 2012 include the international consulting and audit firm Grant Thornton, the engineering and design firm MPR, the medtech PR/IR firm Ronald Trahan Associates Inc., Torreya Partners, The Wallace H. Coulter Foundation, Aurora Capital, Canada, New York Biotechnology Association and AdvaMed2012 the MedTech Conference. For more about OneMedForum SF 2012 visit www.onemedforum.com. To apply to present or for information about sponsorship opportunities, contact: firstname.lastname@example.org.
OneMedPlace is a virtual community that connects emerging companies seeking capital, distribution, and visibility with investors and strategic partners looking for health and medical innovations to invest in, acquire, license, distribute, purchase or utilize.